Swiss National Bank Personalis, Inc. Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$3.27 - $8.76 $259,965 - $696,420	-79,500 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$7.56 - $14.3 $55,188 - $104,390	7,300 Added 10.11%	79,500 $651,000
Q2 2021 Aug 06, 2021	BUY	$18.15 - $27.75 $163,350 - $249,750	9,000 Added 14.24%	72,200 $1.83 Million
Q1 2021 May 07, 2021	BUY	$20.71 - $51.02 $227,810 - $561,220	11,000 Added 21.07%	63,200 $1.56 Million
Q4 2020 Feb 05, 2021	BUY	$21.84 - $44.0 $1.14 Million - $2.3 Million	52,200 New	52,200 $1.91 Million

30.3M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $225M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.